← Back to ABVC

ABVC BioPharma, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 18/05/2026Sep 2025Filed 03/03/2026Jun 2025Filed 12/08/2026Mar 2025Filed 18/05/2026Sep 2024Filed 03/03/2026Jun 2024Filed 13/08/2025Mar 2024Filed 30/04/2025
$0.8$0.4$0.1$0
−$0.7−$1.6−$2−$2.3−$0.8−$0.4−$0.9−$2.8
−$0.03−$0.06−$0.09−$0.13−$0.06−$0.03−$0.08−$0.29
262523171512119.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.